IVERIC bio, Inc. Annual Operating Income (Loss) in USD from 2011 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
IVERIC bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2022.
  • IVERIC bio, Inc. Operating Income (Loss) for the quarter ending March 31, 2023 was -$73.8M, a 113% decline year-over-year.
  • IVERIC bio, Inc. Operating Income (Loss) for the twelve months ending March 31, 2023 was -$229M, a 86.9% decline year-over-year.
  • IVERIC bio, Inc. annual Operating Income (Loss) for 2022 was -$190M, a 65.5% decline from 2021.
  • IVERIC bio, Inc. annual Operating Income (Loss) for 2021 was -$115M, a 29.3% decline from 2020.
  • IVERIC bio, Inc. annual Operating Income (Loss) for 2020 was -$88.7M, a 44.8% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$190M -$75.1M -65.5% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-01
2021 -$115M -$26M -29.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-01
2020 -$88.7M -$27.5M -44.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$61.3M +$4.08M +6.24% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 -$65.3M -$173M -161% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-04
2017 $108M +$304M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 -$196M -$72M -58.3% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 -$124M -$43M -53.4% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-05
2014 -$80.5M -$33.1M -69.8% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 -$47.4M -$33.7M -247% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-26
2012 -$13.7M +$5.95M +30.3% Jan 1, 2012 Dec 31, 2012 10-K/A 2015-07-28
2011 -$19.6M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.